Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case ReportOlav Toai Duc Nguyen, Oluf Dimitri Røe, Stein Sundstrøm et al.|Case Reports in Oncology|2020Cited by 16
‘Reduced’ HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trialOluf Dimitri Røe, Haseem Ashraf, Maria Markaki et al.|BMJ Open Respiratory Research|2019Cited by 15
Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective StudyOlav Toai Duc Nguyen, Oluf Dimitri Røe, Ioannis Fotopoulos et al.|JTO Clinical and Research Reports|2024Cited by 6
Promising microRNAs in pre-diagnostic serum associated with lung cancer up to eight years before diagnosis: a HUNT studyIoannis Fotopoulos, Oluf Dimitri Røe, Robin Mjelle et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 2
Cost‐effectiveness of low‐dose <scp>CT</scp> lung cancer screening among individuals that have ever smoked in Norway: A model‐based analysis using <scp>NELSON</scp> trial criteria and outcomesEmily A. Burger, Natalia Kunst, Dávid Győrbíró et al.|International Journal of Cancer|2025Cited by 1